Lilac Pharma Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
Lilac Pharma General Information
Description
Developer of microchannel devices intended for drug research and development. The company's technology provides manufacturing and product development technology for lipid and polymer nanoparticles used in various fields including pharmaceuticals, enabling organizations to access efficient devices for continuously producing various nanoparticle formulations.
Contact Information
Website
www.lilacpharma.com(Operating Subsidiary)
Corporate Office
- Hokkaido University Campus Hokkaido Industry-Academia-Government Collaboration Center
- Room C, Kita 21-jo Nishi 12-chome, Kita-ku
- Sapporo, Hokkaido 001-0021
- Japan
Corporate Office
- Hokkaido University Campus Hokkaido Industry-Academia-Government Collaboration Center
- Room C, Kita 21-jo Nishi 12-chome, Kita-ku
- Sapporo, Hokkaido 001-0021
- Japan
Lilac Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 09-Dec-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Seed Round | 17-Jan-2018 | $88.9K | $88.9K | Completed | Generating Revenue | |
| 1. Grant | 01-Mar-2016 | $306K | Completed | Generating Revenue |
Lilac Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A |
Lilac Pharma Patents
Lilac Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024119170-A | Pharmaceutical composition, method for producing pharmaceutical composition, and device for producing pharmaceutical composition | Pending | 22-Feb-2023 | ||
| JP-2022052850-A | Manufacturing method of emulsified perfume | Pending | 24-Sep-2020 | ||
| JP-2020050635-A | Biaryl sulfonamide derivative having inhibitory activity against cell invasion of filovirus | Pending | 28-Sep-2018 | ||
| WO-2020067398-A1 | Biaryl sulfonamide derivative having inhibitory activity against cell invasion of filovirus | Inactive | 28-Sep-2018 |
Lilac Pharma Signals
Lilac Pharma Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hokkaido 21st Century Research Institute | Venture Capital | Minority | ||
| Hokuyo Capital | Venture Capital | Minority | ||
| New Energy and Industrial Technology Development Organization | Government | |||
| Startup Hokkaido | Accelerator/Incubator |
Lilac Pharma FAQs
-
When was Lilac Pharma founded?
Lilac Pharma was founded in 2016.
-
Where is Lilac Pharma headquartered?
Lilac Pharma is headquartered in Sapporo, Japan.
-
What is the size of Lilac Pharma?
Lilac Pharma has 10 total employees.
-
What industry is Lilac Pharma in?
Lilac Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Lilac Pharma a private or public company?
Lilac Pharma is a Private company.
-
What is Lilac Pharma’s current revenue?
The current revenue for Lilac Pharma is .
-
How much funding has Lilac Pharma raised over time?
Lilac Pharma has raised $88.9K.
-
Who are Lilac Pharma’s investors?
Hokkaido 21st Century Research Institute, Hokuyo Capital, New Energy and Industrial Technology Development Organization, and Startup Hokkaido have invested in Lilac Pharma.
-
When was Lilac Pharma acquired?
Lilac Pharma was acquired on 09-Dec-2024.
-
Who acquired Lilac Pharma?
Lilac Pharma was acquired by Nippon Shokubai.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process